Xibin Xia

机构：Central South University, Hunan Cancer Hospital

发表论文 6 篇 · 总被引 63 次 · h-index 4

代表论文

• Prediction of therapeutic response of unresectable hepatocellular carcinoma to hepatic arterial infusion chemotherapy based on pretherapeutic MRI radiomics and Albumin-Bilirubin score (2022 · Journal of Cancer Research and Clinical Oncology · 被引 24)
• Predictive value of DCE-MRI and IVIM-DWI in osteosarcoma patients with neoadjuvant chemotherapy (2022 · Frontiers in Oncology · 被引 15)
• Exosome-derived miR-23a-5p inhibits HCC proliferation and angiogenesis by regulating PRDX2 expression (2023 · Heliyon · 被引 13)
• The Predictive Role of Inflammatory Biomarkers for Treatment Response and Progression-Free Survival in Patients with Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy with FOLFOX Regimen: A Preliminary Study (2023 · Journal of Hepatocellular Carcinoma · 被引 10)
• Application of the novel tracer mitoxantrone hydrochloride in lymph node visualization during lateral neck dissection for thyroid carcinoma (2025 · Frontiers in Endocrinology · 被引 1)
• Differentiating true progession from pseudoprogression in patients with gliobastomas using dynamic contrast-enhanced MRI (2017)